GE HealthCare Technologies (NASDAQ:GEHC) reported third-quarter 2026 revenue growth across all of its business segments, supported by demand in imaging and pharmaceutical diagnostics, improved execution in patient care products and margin expansion. Revenue totaled $5.5 billion, rising 6.2% organically from a year earlier. Reported product revenue increased 6.7%, while service revenue rose 8.1%. Organic orders […]
GE HealthCare Technologies (NASDAQ:GEHC) reported third-quarter 2026 revenue growth across all of its business segments, supported by demand in imaging and pharmaceutical diagnostics, improved execution in patient care products and margin expansion. Revenue totaled $5.5 billion, rising 6.2% organically from a year earlier. Reported product revenue increased 6.7%, while service revenue rose 8.1%. Organic orders […]This article was originally published by Daily Political.
Read Full Story on Source Site →
